AiRPaDD: Advancing Reaction Platforms for Drug Discovery

AiRPaDD：推进药物发现的反应平台

• 批准号: EP/X02525X/1
• 负责人: Joseph Harrity
• 金额: $ 33.8万
• 依托单位: University of Sheffield
• 依托单位国家: 英国
• 项目类别: Research Grant
• 财政年份: 2023
• 资助国家: 英国
• 起止时间: 2023 至 无数据
• 项目状态: 未结题
• 来源: https://gtr.ukri.org/projects?ref=EP%2FX02525X%2F1
• 关键词: AiRPaDD; Advancing; Reaction; Platforms; Drug

This Action will contribute to the sustainable development of European chemical industries in the coming decades by delivering an ambitious doctoral training programme that draws on expertise from industry and academia across 4 European countries. The research agenda and experiential training will grow the skills base beyond approaches that have relied upon a limited set of molecular scaffolds and a relatively small sub-set of reactions to exploit new reaction paradigms and platforms (e.g. high throughput experimentation, photoredox & electrochemistry) that meet the needs of modern drug discovery science.

该行动将通过提供一个雄心勃勃的博士培训计划，利用来自4个欧洲国家的工业和学术界的专业知识，为未来几十年欧洲化学工业的可持续发展做出贡献。研究议程和体验式培训将发展技能基础，超越依赖于有限的分子支架和相对较小的反应子集的方法，以开发新的反应范式和平台（例如高通量实验，光氧化还原和电化学），以满足现代药物发现科学的需求。